Enzymotec has added a new product to its cognitive line of products called: SharpPS gold, a PS-DHA conjugate. SharpPS gold follows the natural PS structure found in the human brain and emulates the historical compound originally extracted from bovine brain. "This unique composition enables a potent biofunctionality and DHA/PS synergy, which translates into a significant cognitive improvement, compared to any other alternative such as: "regular" DHA or PS." Sais Dr. Yaniv Dolev, newly appointed US Marketing manager of Enzymotec.
There are currently 600 million people in the world who are aged 60 years or older, a figure expected to double by 2025 and reach 2 billion by 2050. According to the US census bureau, there are more than 60 million Americans over the age of 55, which is 22% of the population. Similar figures exist in other western countries.
Aging has long been associated with mental and cognitive decline. Moreover, age-related illnesses such as Alzheimer's or Dementia are also associated with a sharp, irreversible decrease of mental and cognitive capabilities, which affects the quality of life of the patient as well as the people that surround him. For some time it has been the focus of major prodcuts launches including those of functional foods with omega-3. Industry sources estimate the current US cognitive market at 350 M$.
PhosphatidylSerine and DHA have long been associated with proper cognitive functioning and their presence or absence is strongly correlated to proper mental development and functioning.
"We believe that one of the barriers, which limits DHA's maximal cognitive impact is its relatively poor brain bioavailability. In addition to our ability to produce this material with our advanced processing technology, we have also been able to clinically demonstrate the effectiveness of this PS form , providing superior brain bioavailability of DHA together with superior cognitive efficacy". concludes Dr. Dolev
Enzymotec is an Israeli biotech company, that is developing and producing health ingredients for dietary supplements and functional foods.
The company's leading product categories are: InFat for balanced nutrition in infant formula, SharpPS for cognitive performance improvement of seniors and CardiaBeat offering a broad health effect to reduce CVD risks.